Rallis India Limited · NSE:RALLIS
Rallis India — Q3 FY21 Earnings Presentation
15 slides from Rallis India's earnings presentation, January 2021
Slide 1: Results Presentation Q3 FY21
Results Presentation Q3 FY21 1
Slide 2: Disclaimer
Disclaimer This presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expressions or variatio
Slide 3: Rallis – Areas of Strength
Rallis – Areas of Strength Well entrenched connect with the Indian farmer Chemistry ● Crop Protection ● Partnering with global (International Plant growth innovators (Domestic ● business) Strong R&D and business) ● ● Nutrients(PGN) executional capabilities ● Soil conditioner ● Environmentally ● Seed
Slide 4: Domestic business
Domestic business Leading Agrochemical Company Presence across value chain: Seeds – Soil Conditioners – Crop Protection Chemicals - Plant Growth Nutrients Market share: ~ 6% (Crop protection & PGN), ~3% (Seeds) Strong & Healthy pipeline of sustainable products Nationwide footprint – more than 3700+
Slide 5: International Business – Primed for growth
International Business – Primed for growth Alliances Contract Manufacturing • Developing Technicals for global Agro chemicals players • Manufacturing molecules for global chemical players • Key products • Key products - One Polymer and One Fungicide – Pendimethalin: Used as a pre-emergence herbicide
Slide 6: Seed business
Seed business Rallis develops, produces and sells hybrid seeds including Paddy, Millet, Maize and Bt Cotton with main exposure (80-85%) to the Kharif season Strong market position - among top 3 in Hybrid Paddy (3rd) & Hybrid Millet (2nd) and Maize (6th). With around a million packets sold, our Bt Co
Slide 7: Strategic Initiatives
Strategic Initiatives Domestic business • Customer connect through digital campaigns • New Brand Architecture introduced • Increase focus on new product launches; portfolio optimisation • Improve connect between distributors and company Refresh distribution channel : Add distributors to enhance grow
Slide 8: Q3 & YTD FY21 - Performance Highlights: Overall
Q3 & YTD FY21 - Performance Highlights: Overall Rs Crs ● The company witnessed a 7% growth ● Overall EBITDA % remained at ● Growth in PAT is reflective of sales in revenues QoQ. Crop Care grew by similar level to PY i.e. @ 10.5% & EBITDA growth. 5% QoQ and Seeds by 38% ● 15% revenue growth on QoQ ba
Slide 9: Q3 FY21 & YTD FY21 - Performance Highlights: Crop Care division
Q3 FY21 & YTD FY21 - Performance Highlights: Crop Care division Rs Cr ● Crop care division witnessed a 5% increase in revenues QoQ ● Growth in PAT is reflective of ● EBITDA % increased in Crop care by sales & EBITDA growth. ● 15% revenue growth on QoQ basis in 213 basis points i.e. CY @ 15.5% as the
Slide 10: Q3 FY21 & YTD FY21 - Performance Highlights: Rallis Seeds Division
Q3 FY21 & YTD FY21 - Performance Highlights : Rallis Seeds Division Rs Cr ● Drop in EBITDA is due to drop in ● Seeds grew by 38% mainly due to Gross margins - (Low yield in volume growth in Maize & bajra Paddy/Bajra) ● PAT movement for the quarter ● Better price realisation in Maize, mirrors EBITDA
Slide 11: Category-wise Revenue Split Q3 & YTD
Category-wise Revenue Split Q3 & YTD Category Wise Break-up Note: Price corrections in Metribuzin impacting Herbicide Pl note that these revenue breakups are for Crop revenue compared to PY Protection 11 Copyright © Rallis India Limited. All rights reserved.
Slide 12: Revenue Split Domestic/International Q3 & YTD
Revenue Split Domestic/International Q3 & YTD Category wise Q3 YTD Note: Price correction in Metribuzin coupled with drop in Pl note that these revenue breakups are for Crop Contract Manufacturing Volumes leading to overall drop in Protection % share of International revenue 12 Copyright © Rallis In
Slide 13: Capex - Update
Capex - Update • Overall Capex implementation impacted due to COVID 19 & monsoons : delayed by 2- 3 months • Formulation Plant at Dahej, CZ - Phase 1 expected to be completed by March 21 • Capacity Expansion of Metribuzin, Hexaconazole and, Kresoxim Methyl completed during the quarter • Capacity exp
Slide 14: Operational Highlights
Operational Highlights New Product Progress – ❖ Launched new 9(4) formulation in Q3 - Trot (Thiamethoxam FS) targeted as a seed treatment insecticide for Cotton, Soybean, Chilli, Sorghum, Wheat, Okra, Maize, Sunflower and Groundnut ❖ Registration Approved: for Acephate 75% SP by Health Ministry ANVI
Slide 15: Thank You
THANK YOU 15 Copyright © Rallis India Limited. All rights reserved.